IN2013MU03772A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03772A
IN2013MU03772A IN3772MU2013A IN2013MU03772A IN 2013MU03772 A IN2013MU03772 A IN 2013MU03772A IN 3772MU2013 A IN3772MU2013 A IN 3772MU2013A IN 2013MU03772 A IN2013MU03772 A IN 2013MU03772A
Authority
IN
India
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
ppm
Prior art date
Application number
Other languages
English (en)
Inventor
Dhileepkumar Krishnamurthy
Raghavendar Rao Morthala
Ashutosh Jagtap
Prashant Ladkat
Ajay Kumbhar
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Priority to PCT/IB2014/066279 priority Critical patent/WO2015083033A1/en
Priority to IN3772MU2013 priority patent/IN2013MU03772A/en
Publication of IN2013MU03772A publication Critical patent/IN2013MU03772A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN3772MU2013 2013-12-02 2014-11-24 IN2013MU03772A (enrdf_load_html_response)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/066279 WO2015083033A1 (en) 2013-12-02 2014-11-24 An improved process for the preparation of fosaprepitant having improved purity
IN3772MU2013 IN2013MU03772A (enrdf_load_html_response) 2013-12-02 2014-11-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3772MU2013 IN2013MU03772A (enrdf_load_html_response) 2013-12-02 2014-11-24

Publications (1)

Publication Number Publication Date
IN2013MU03772A true IN2013MU03772A (enrdf_load_html_response) 2015-07-31

Family

ID=53272958

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3772MU2013 IN2013MU03772A (enrdf_load_html_response) 2013-12-02 2014-11-24

Country Status (2)

Country Link
IN (1) IN2013MU03772A (enrdf_load_html_response)
WO (1) WO2015083033A1 (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106432337A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 福沙匹坦衍生物、合成和在长效制剂中的用途
CN109608498A (zh) * 2018-12-25 2019-04-12 四川制药制剂有限公司 一种福沙匹坦超临界反应制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR051475A1 (es) * 2004-11-05 2007-01-17 Merck & Co Inc Procedimiento para acido{3- [2 (r) -[(1r) - 1-[ 3,5- bis( trifluorometil)- fenil] etoxi] -3 (s) - (4- fluorfenil) morfolin -4- il]metil -5-oxo-4,5-dihidro- [1,2,4]-triazol-1-il} fosfonico
EP2714701B1 (en) * 2011-06-03 2016-07-13 Hetero Research Foundation Process for fosaprepitant
WO2013168176A2 (en) * 2012-03-30 2013-11-14 Glenmark Generics Limited Process for preparation of fosaprepitant and salt thereof

Also Published As

Publication number Publication date
WO2015083033A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
NZ716487A (en) Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
EA201492092A1 (ru) Соединения и композиции для ингибирования активности abl1, abl2 и bcr-abl1
EA201590450A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
PH12015502116A1 (en) Biaryl amide compounds as kinase inhibitors
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
IN2014KN00948A (enrdf_load_html_response)
PH12015500457A1 (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
EA201390422A1 (ru) Бупренорфиновые аналоги
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
EA201290837A1 (ru) Лечение волчаночного нефрита с применением лаквинимода
MX355153B (es) Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biologico.
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
MX388849B (es) Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas.
GEP201706741B (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
MX342924B (es) Nuevos compuestos disustituidos de 3,4-diamino-3-ciclobuteno-1,2-d iona para uso en el tratamiento de patologias mediadas por quimiocinas.
EA201590221A1 (ru) Способ усовершенствованного синтеза опиоидов
MX379558B (es) Nueva forma cristalina de n-[5-(3,5-difluoro-bencilo)-1h-indazol-3-il]-4-(4-metilo-piperazina-1-il)-2-(tetrahidro-pirano-4-ilamino)-benzamida.
MX354373B (es) Proceso para hacer compuestos de ciclopentapirimidina hidroxilada y sus sales.
TN2014000112A1 (en) Ep1 receptor ligands
EA201791321A1 (ru) Составы ингибитора lfa-1
MY173636A (en) Method of treating dengue fever
EA200900463A1 (ru) Арипипразола гемифумарат и способ его получения
MX350443B (es) Proceso para hacer compuestos de aminoácidos.
IN2013MU03772A (enrdf_load_html_response)